KRRAIL stock news
This page provides real-time market news, earnings updates, and company announcements related to K&R Rail Engineering Ltd. (KRRAIL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-21 21:16 IST
A detailed overview of technology layoffs in 2025
Bitget-RWA2025-11-26 22:27:51

The Influence of Evolving Academic Research on Industries Powered by STEM
Bitget-RWA2025-12-08 14:32:11
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
101 finance2026-01-13 13:21:24
I Owe $120,000 in Student Loans and Earn $80,000 Annually. Is It Better to Stick With Minimum Payments?
101 finance2026-01-22 12:39:32
Inside KPMG’s Orlando Lakehouse: the $450 million pandemic misstep now turning into a hidden asset for the AI era
101 finance2026-01-25 15:57:28
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Finviz2026-02-12 13:36:12

Craig L. Nix Appointed to Sonoco Board of Directors
Finviz2026-02-12 14:03:39

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Finviz2026-02-12 21:09:36

Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
Finviz2026-02-12 21:09:36

Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44

Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-02-17 12:03:44

Watsco Reports Record Full-Year Gross Margin, Meets Inventory Reduction Target and Generates Record 4th Quarter Cash Flow in Challenging Market Conditions
Finviz2026-02-17 12:33:44

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37

Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel
Finviz2026-02-17 17:21:49

Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Finviz2026-02-18 13:06:40

Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Finviz2026-02-18 13:06:40
Elizabeth Warren Slams Amazon's Massive Tax Break Under Trump, Says It Would Take 100,000 Years For Average US Household To Match
Finviz2026-02-19 08:15:41

Occidental Announces Cash Tender Offers and Consent Solicitations for Certain of its Senior Notes and Debentures
Finviz2026-02-19 11:48:56

Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting
Finviz2026-02-19 12:03:41

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
Finviz2026-02-19 12:03:41

Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
Finviz2026-02-19 14:03:34

Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
Finviz2026-02-19 14:03:34

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-19 21:03:59
Inside KPMG’s Orlando Lakehouse: the $450 million pandemic misstep now turning into a hidden asset for the AI era
101 finance2026-01-25 15:57:28
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Finviz2026-02-12 13:36:12

Craig L. Nix Appointed to Sonoco Board of Directors
Finviz2026-02-12 14:03:39

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Finviz2026-02-12 21:09:36

Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
Finviz2026-02-12 21:09:36

Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44

Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-02-17 12:03:44

Watsco Reports Record Full-Year Gross Margin, Meets Inventory Reduction Target and Generates Record 4th Quarter Cash Flow in Challenging Market Conditions
Finviz2026-02-17 12:33:44

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37

Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel
Finviz2026-02-17 17:21:49

Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Finviz2026-02-18 13:06:40

Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
Finviz2026-02-18 13:06:40
Elizabeth Warren Slams Amazon's Massive Tax Break Under Trump, Says It Would Take 100,000 Years For Average US Household To Match
Finviz2026-02-19 08:15:41

Occidental Announces Cash Tender Offers and Consent Solicitations for Certain of its Senior Notes and Debentures
Finviz2026-02-19 11:48:56

Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting
Finviz2026-02-19 12:03:41

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
Finviz2026-02-19 12:03:41

Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
Finviz2026-02-19 14:03:34

Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
Finviz2026-02-19 14:03:34

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-19 21:03:59
KRRAIL stock price change
On the last trading day, KRRAIL stock closed at 31.92 INR, with a price change of 0.41% for the day.
Trade stock futuresKRRAIL stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more